Clinical trial
Valine 50mg/ml and Isoleucine 25mg/ml Oral Solutions for Maple Syrup Urine Disease (MSUD) - Acceptability and Tolerance Study
NCT06581991 is registered in ClinicalTrials.gov with Meta Healthcare Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Valine 50mg/ml and Isoleucine 25mg/ml Oral Solutions for Maple Syrup Urine Disease (MSUD) - Acceptability and Tolerance Study
- Lead sponsor
- Meta Healthcare Ltd
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2024
- Completion date
- September 30, 2026
- Enrollment
- 5 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.